Category: misconduct investigations

Child psychiatrist’s research was suspended “indefinitely” following probe

Mani Pavuluri

The University of Illinois at Chicago (UIC) permanently suspended all research activities for a child psychiatrist years ago following an inquiry into her work, Retraction Watch has learned.

In 2015, a UIC spokesperson told us the university had suspended Mani Pavuluri’s clinical research in 2013, after a child in one of her studies had been hospitalized for exhibiting an increase in irritability and aggression. This prompted the university to launch a misconduct probe, and send letters to approximately 350 families of children participating in the research, notifying them of what happened. Now, a spokesperson has informed us that after the institution concluded its probe, it suspended her research “indefinitely.”

Continue reading Child psychiatrist’s research was suspended “indefinitely” following probe

Caught Our Notice: Researcher who sued PubPeer commenter up to 21 retractions

Titles: 1) Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells

2) Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents

What Caught Our Attention: Regular readers will be familiar with the saga involving Fazlul Sarkar and PubPeer: In 2014, Sarkar sued anonymous commenters on the site, claiming defamation (and that damaging comments may have cost him a new job). Although Sarkar won an initial ruling, it was overturned by an appeals court. In the midst of that, the ACLU (which represented PubPeer in the case) released a copy of a misconduct investigation report compiled by Sarkar’s institution, Wayne State University, which concluded that he had committed enough misconduct to warrant retracting 40 papers. The two latest notices, both of which cite Wayne State’s investigation, bring Sarkar’s total to 21.   Continue reading Caught Our Notice: Researcher who sued PubPeer commenter up to 21 retractions

Paper used to support WHO guidelines on preventing infections “has no scientific validity”

A surgery journal retracted a 2014 paper last month after discovering that the study has “no scientific validity.”

Mario Schietroma and his coauthors, based at the University of L’Aquila in Italy, reported that giving patients high concentrations of oxygen during and after colorectal surgery significantly reduced their risk of infections. Although the authors reported significant p-values, the retraction notice states that, “upon recalculation, no p-values were close to significant.” The University of L’Aquila told Retraction Watch it is investigating, but did not provide details. Continue reading Paper used to support WHO guidelines on preventing infections “has no scientific validity”

Caught Our Notice: Former rising star loses fourth paper

Title: Haemophilus influenzae responds to glucocorticoids used in asthma therapy by modulation of biofilm formation and antibiotic resistance

What Caught Our Attention: This is the fourth retraction for Robert Ryan, formerly a high-profile researcher studying infections that can be deadly in people with lung diseases such as cystic fibrosis. In 2016, the University of Dundee in Scotland determined that Ryan had committed research misconduct, including misrepresenting clinical data and duplicating images in a dozen different publications. (Ryan tried to appeal the decision, then resigned.) The latest retraction cites a few problems with the paper, including uncertainty about the provenance of some data.

According to the notice, the second-to-last author, George A. O’Toole at Dartmouth, disagrees with the text of the notice, not the decision to retract. We contacted O’Toole, who declined to comment.

We received a statement from Ryan about the retraction:

Continue reading Caught Our Notice: Former rising star loses fourth paper

UCSF-VA investigation finds misconduct in highly cited PNAS paper

PNAS has corrected a highly cited paper after an investigation found evidence of misconduct.

The investigation—conducted jointly by the University of California, San Francisco, and the San Francisco Veterans Administration Medical Center—uncovered image manipulation in Figure 2D, which “could only have occurred intentionally.” The institutions, however, could not definitively attribute the research misconduct to any individual.

According to the notice, the UCSF-VA committee determined that a correction to the 2008 PNAS paper—which explores the genetic underpinnings of prostate cancer—was “appropriate,” and the authors have now replaced the problematic figure with a corrected version. The 2008 paper has been cited 630 times, according to Clarivate Analytics’ Web of Science.

A spokesperson for PNAS told Retraction Watch: Continue reading UCSF-VA investigation finds misconduct in highly cited PNAS paper

Probe finds misconduct in eight papers by researcher in Sweden

Suchitra Sumitran-Holgersson, via the University of Gothenburg

An external probe has concluded that a researcher based at the University of Gothenburg committed misconduct in multiple papers, all of which should be withdrawn.

Among 10 papers by Suchitra Sumitran-Holgersson at the University of Gothenburg, an Expert Group concluded that eight contained signs of scientific misconduct. The Expert Group, part of Sweden’s Central Ethical Review Board, also found evidence of problems within her laboratory environment.

In an email to Retraction Watch, Sumitran-Holgersson denied any “willful manipulation of data.”

According to the report (in Swedish, which we translated using Google):

Continue reading Probe finds misconduct in eight papers by researcher in Sweden

“Clear signs of manipulation” in paper co-authored by prominent geneticist

David Latchman

A third paper co-authored by researchers based at a prominent lab whose work has been under investigation on and off for almost three years has been retracted.

According to the notice, the university’s investigation found that a 2008 paper in FEBS Letters contained “clear signs of manipulation” in three figures.

Research from geneticist David Latchman’s group has been dogged by misconduct allegations since late 2013 and subject to two investigations by the University College London (UCL). Continue reading “Clear signs of manipulation” in paper co-authored by prominent geneticist

Former NYU researcher falsified data in 3 papers, 7 grants: ORI

A former researcher at New York University falsified and/or fabricated data in multiple papers and grant applications, according to the U.S. Office of Research Integrity.

Bhagavathi Narayanan has already retracted three papers, the result of missing original data. Among the three papers flagged by the ORI, only one remains intact: A 2011 paper in Anticancer Research.

According to the ORI:

Continue reading Former NYU researcher falsified data in 3 papers, 7 grants: ORI

Delays, arguing over upcoming Cell retraction leave first author “devastated”

After being “blindsided” a few months ago when she was told one of her 2005 papers was going to be retracted, a researcher scrambled to get information about why. And when she didn’t like the answers, she took to PubPeer.

Eight days ago, Shalon (Babbitt) Ledbetter, the first author of the 2005 paper published in Cell, posted a comment on the site announcing the paper was going to be retracted after the last author’s institution, Saint Louis University (SLU), determined that some figures had been manipulated by the last author, Dorota Skowrya. A letter dated September 2, 2015 sent by SLU to Cell describes the results of the investigation — namely, that the manipulations were “cosmetic,” and had no effect on the data or the conclusions. More than two years later, Ledbetter learned the journal was planning to retract the paper, and an initial draft of the notice wouldn’t identify who was responsible; she has since been pulled into a confusing web of blame-shifting and conflicting information that has been, in her words, “heartbreaking.”

Ledbetter wrote on PubPeer:

Continue reading Delays, arguing over upcoming Cell retraction leave first author “devastated”

Probe into Carlo Croce reached “defensible and reasonable” decisions, says external review

An independent analysis of how The Ohio State University reviewed allegations of misconduct against a high-profile cancer researcher has found that the institution “complied with applicable law and with relevant institutional policies and reached reasoned and supportable conclusions.”

The review follows numerous allegations of research misconduct against Carlo Croce, described in a March 8 story in the New York Times. According to the Times article, Croce has been the subject of multiple investigations; at least five of those inquiries from OSU cleared him of wrongdoing. 

Croce has denied the allegations, and is now suing the New York Times and an outside researcher who served as a key source in the story. As a result of the story, however, OSU — where Croce is based — told us last year it had “launched an independent review of our systems for ensuring research integrity.”

Continue reading Probe into Carlo Croce reached “defensible and reasonable” decisions, says external review